Loading…
P3 Health Partners Inc. is projected to rise to $10.04 by 2027, a +2% move from its current price of $9.80. PIII is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $9.20 | $9.81 | $10.46 | +0.08% |
| Jul 15 | $8.97 | $9.82 | $10.75 | +0.17% |
| Jul 16 | $8.79 | $9.82 | $10.98 | +0.25% |
| Jul 17 | $8.65 | $9.83 | $11.18 | +0.34% |
| Jul 18 | $8.53 | $9.84 | $11.36 | +0.42% |
| Jul 19 | $8.42 | $9.85 | $11.52 | +0.50% |
| Jul 20 | $8.32 | $9.86 | $11.68 | +0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.32 | $9.86 | $11.68 | +0.59% |
| Week 2 | $7.80 | $9.92 | $12.60 | +1.18% |
| Week 3 | $7.44 | $9.97 | $13.37 | +1.77% |
| Week 4 | $7.15 | $10.03 | $14.08 | +2.37% |
| Week 5 | $6.91 | $10.09 | $14.74 | +2.97% |
| Week 6 | $6.70 | $10.15 | $15.37 | +3.58% |
| Week 7 | $6.52 | $10.21 | $15.98 | +4.18% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
P3 Health Partners Inc. is a patient-centered and physician-led population health management company that provides superior care services in the United States.
It operates clinics and wellness centers.
The company was founded in 2020 and is based in Henderson, Nevada.
PIII is a healthcare company trading at $10.29. It has a market cap of $2.09B and is ranked 1989.
The forecast shows a near-term plateau with a 2026 average price of $10.29 and a 0% ROI, indicating a neutral stance in that year. 2027 offers a modest uptick with an average of $10.84 and a 5.3% ROI, moving toward a bullish trajectory in the following years.
From 2028 onward, the average price rises significantly, with 2028 at $15.57 (51.3% ROI) and 2029 at $21.51 (109% ROI), and then stronger gains into 2030 ($22.44, 118.1% ROI) and beyond. The long-range outlook strengthens further with 2040 averaging $52.35 (408.8% ROI) and 2050 averaging $144.69 (1306.1% ROI).
A major floor 77.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 68.1% above — a clean break opens room to run.
A major ceiling 90.7% above — clearing it would confirm fresh momentum.
Key PIII support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PIII market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.11 | Sell | $10.15 | Sell |
| MA 10 | $10.71 | Sell | $10.52 | Sell |
| MA 20 | $11.15 | Sell | $10.80 | Sell |
| MA 50 | $9.69 | Buy | $9.57 | Buy |
| MA 100 | $6.16 | Buy | $7.76 | Buy |
| MA 200 | $5.93 | Buy | $7.26 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.70 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -138.76 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.33 | Sell |
| ROC (12) | -18.27 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.33 | Buy |
| Awesome (5,34) | -1.78 | Sell |
| Ultimate (7,14,28) | 36.33 | Neutral |
| Momentum (10) | -0.88 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 9.69 | Buy |
| ADX (14) | 11.75 | Neutral |
| ATR (14) | 0.63 | Info |
The 30-day technical picture is BULLISH, with RSI14 at 50, suggesting neutral momentum near the cusp of a momentum shift. SMA50 is $9.10 and SMA200 is $5.89, indicating the near-term trend is supported by moving averages.
A near-term support level sits at $10.05 and a resistance level at $16.47, framing the key price zone. The 30-day price range spans from $6.42 to $16.50, illustrating notable volatility within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.52 | $9.80 | $14.68 | 0% | Neutral | |
| $7.29 | $10.04 | $14.96 | +2% | Neutral | |
| $9.46 | $13.85 | $22.00 | +41% | Bullish | |
| $12.49 | $19.26 | $32.11 | +97% | Bullish | |
| $12.47 | $20.17 | $34.99 | +106% | Bullish | |
| $14.50 | $24.51 | $44.02 | +150% | Bullish | |
| $14.15 | $24.94 | $46.20 | +155% | Bullish | |
| $12.03 | $22.09 | $42.05 | +125% | Bullish | |
| $13.00 | $24.83 | $48.47 | +153% | Bullish | |
| $15.08 | $29.94 | $59.79 | +205% | Bullish | |
| $19.64 | $43.64 | $95.79 | +345% | Bullish | |
| $54.05 | $120.11 | $276.25 | +11.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.52 | $9.80 | $12.37 | +0.00% |
| August 2026 | $8.96 | $10.84 | $13.67 | +10.63% |
| September 2026 | $8.61 | $10.58 | $13.61 | -2.45% |
| October 2026 | $8.10 | $10.07 | $13.19 | -4.80% |
| November 2026 | $8.38 | $10.52 | $13.98 | +4.49% |
| December 2026 | $8.60 | $10.90 | $14.68 | +3.63% |
Click any year to see its month-by-month PIII forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The PIII price prediction for 2026 points to an average of $9.80 (low $1.52, high $14.68) — a potential gain of 0% on today's $9.80. Price action looks broadly range-bound.
In 2027, PIII is projected to trade between $7.29 and $14.96, averaging $10.04 — a potential gain of +2% from today's $9.80. That is up +2% on the projected 2026 average. A consolidation phase looks the most probable path here.
P3 Health Partners Inc.'s 2028 outlook centres on $13.85, within a $9.46 to $22.00 range. That is up +38% on the projected 2027 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2029, PIII could reach as high as $32.11, with a base case around $19.26 and support toward $12.49 — roughly +97% from $9.80. Buyers look set to stay in control over this stretch.
Expect PIII to range from $12.47 to $34.99 through 2030. The $20.17 average target implies a +106% move from current prices. That is up +5% on the projected 2029 average. Momentum favours further upside here.
The PIII price prediction for 2031 points to an average of $24.51 (low $14.50, high $44.02) — a potential gain of +150% on today's $9.80. Buyers look set to stay in control over this stretch.
In 2032, PIII is projected to trade between $14.15 and $46.20, averaging $24.94 — a potential gain of +155% from today's $9.80. That is up +2% on the projected 2031 average. Momentum favours further upside here.
P3 Health Partners Inc.'s 2033 outlook centres on $22.09, within a $12.03 to $42.05 range. That is -11% versus the projected 2032 average. That marks a +125% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, PIII could reach as high as $48.47, with a base case around $24.83 and support toward $13.00 — roughly +153% from $9.80. Momentum favours further upside here.
Expect PIII to range from $15.08 to $59.79 through 2035. The $29.94 average target implies a +205% move from current prices. That is up +21% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The PIII price prediction for 2040 points to an average of $43.64 (low $19.64, high $95.79) — a potential gain of +345% on today's $9.80. Momentum favours further upside here.
In 2050, PIII is projected to trade between $54.05 and $276.25, averaging $120.11 — a potential gain of +11.3x from today's $9.80. That is up +175% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in PIII today (≈ 102.040816 PIII) could be worth
$12,255.9
+$11,255.9 (+1126%) by 2050 · US Dollar
Based on the average projected PIII price of $120.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PIIIwould be worth at today's price.
$1,000 invested in PIII on Jul 10, 2025 (≈ 160.513643 PIII) would be worth
$1,573.03
+$573.03 (+57.3%) today · 1.57× · US Dollar
Based on a PIII entry price of $6.23 vs. today's $9.8.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.37 | $861.92 | -13.8% |
| 1 month ago | $13.54 | $723.78 | -27.6% |
| 3 months ago | $2.54 | $3,858.27 | +285.8% |
| 6 months ago | $2.95 | $3,322.03 | +232.2% |
| 1 year ago | $6.23 | $1,573.03 | +57.3% |
| All time (5.0y) ago | $495 | $19.8 | -98.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PIII forecast.
Our base-case forecast reaches $20.00 around 2030.
Implied market cap at $20.00: $66.52M
The multi-year forecast shows a clear bullish trajectory after 2027, with rising average prices and strong ROI into the 2030s and 2040s. The 2030 average is $22.44 with an ROI of 118.1% and a bullish sentiment, while the 2040 average climbs to $52.35 with an ROI of 408.8% and continued bullishness. By 2050, the average is projected at $144.69 with an ROI of 1306.1% and a bullish sentiment.
Key intermediate years reinforce the acceleration: 2028 average $15.57 (ROI 51.3%), 2029 average $21.51 (ROI 109%), 2031 average $27.87 (ROI 170.9%), and 2032 average $28.04 (ROI 172.5%). While 2026-2027 show neutral signals, the longer horizon is characterized by substantial upside potential, albeit with the usual uncertainty inherent in forecasts.
Tap a question to reveal the answer.
2030 avg $22.44; min $13.86; max $38.96; ROI 118.1%; sentiment BULLISH.
Forecasts show a bullish sentiment from 2028 onward with rising averages; 2027 avg $10.84 (ROI 5.3%), 2028 avg $15.57 (ROI 51.3%), 2029 avg $21.51 (ROI 109%), 2030 avg $22.44 (ROI 118.1%). These are estimates, not guarantees.
Yes, according to the max forecasts, the 2040 max is $114.95 and the 2050 max is $332.78.
The 30-day technical picture is bullish with RSI14 at 50; SMA50 at $9.10; SMA200 at $5.89; support $10.05; resistance $16.47; 30-day range from $6.42 to $16.50.
Current price is $10.29 and market cap is $2.09B; rank 1989.
P3 Health Partners Inc. Community Discussion
0Share your P3 Health Partners Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.